{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4584/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":2138.5625,"timestamp":1774295999999,"preClose":2134.8713,"halted":0,"volume":12117452,"delay":0,"changeRate":0.001729,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":3.691162,"latestTime":"03-23 16:00:00 EDT","open":2150.8262,"high":2184.1477,"low":2129.9165,"amount":164173756.008417,"amplitude":0.025403,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774359000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.341111,"peRate":25.237546,"turnoverRate":0.007975,"increases":3,"decrements":2,"flats":0,"marketCap":34353940654,"floatMarketCap":33652961166},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2184.1477,"amplitude":0.025403,"preClose":2134.8713,"low":2129.9165,"pbRate":"4.341111","latestPrice":2138.5625,"volume":12117452,"delay":0,"open":2150.8262,"prevYearClose":2379.9924,"prevWeekClose":2134.8713,"prevMonthClose":2521.1123,"prevQuarterClose":2379.9924,"fiveDayClose":2196.147,"twentyDayClose":2570.1104,"sixtyDayClose":2409.9392,"secType":"PLATE","market":"US","turnoverRate":0.007975,"peRate":25.237546,"marketCap":34353940654,"floatMarketCap":33652961166,"timestamp":1774295999999,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":3,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618320955","title":"Femasys advances FemBloc to U.S. approval with initiation of trial enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2618320955","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618320955?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:17","pubTimestamp":1773148657,"startTime":"0","endTime":"0","summary":"Femasys (FEMY) announced the initiation of patient enrollment in the FINALE pivotal clinical trial evaluating FemBloc. This milestone follows U.S. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-advances-fembloc-to-u-s-approval-with-initiation-of-trial-enrollment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-advances-fembloc-to-u-s-approval-with-initiation-of-trial-enrollment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","FEMY","BK4539","BK4584"],"gpt_icon":0},{"id":"2618955510","title":"Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2618955510","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618955510?lang=en_us&edition=fundamental","pubTime":"2026-03-10 21:00","pubTimestamp":1773147600,"startTime":"0","endTime":"0","summary":"-- Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ATLANTA, March  10, 20","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/10/3252904/0/en/Femasys-Advances-FemBloc-Toward-U-S-Approval-with-Initiation-of-Pivotal-Trial-Enrollment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDE","BK4539","FEMY","ITI","BK4157","BK4082","BK4584"],"gpt_icon":0},{"id":"2618297096","title":"MannKind to Present New Data From Pediatric and Adult Studies of Afrezza® at ATTD 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618297096","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618297096?lang=en_us&edition=fundamental","pubTime":"2026-03-09 21:05","pubTimestamp":1773061500,"startTime":"0","endTime":"0","summary":"Presentations highlight realworld dosing and titration patterns in youth, and postprandial glucose management strategies using inhaled insulin in both adults and youth with T1DData to be featured acro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3251909/29517/en/MannKind-to-Present-New-Data-From-Pediatric-and-Adult-Studies-of-Afrezza-at-ATTD-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNKD","BK4139","BK4584","RAA"],"gpt_icon":0},{"id":"2618626684","title":"Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2618626684","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618626684?lang=en_us&edition=fundamental","pubTime":"2026-03-09 20:30","pubTimestamp":1773059400,"startTime":"0","endTime":"0","summary":"-- The Phase 2b study to assess enobosarm’s ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/09/3251811/11676/en/Veru-Enrolls-First-Patient-in-Phase-2b-PLATEAU-Clinical-Trial-of-Enobosarm-and-Semaglutide-Combination-for-High-Quality-Weight-Loss.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VERU","BK4007","BK4183","BK4584","BK4557"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":24,"code":"91000000","status":"200"}]}}